AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2005
Oct 7, 2005
30339_dirs_2005-10-07_8d59e2ed-17b6-422f-8c41-c33cff33be59.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-10-01
Reporting Person: McMillan Donald A (President Pharma Systems NA)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 8737.4538 | Direct |
| Common Stock | 5671.6033 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $11.2950 | 2008-04-28 | Common Stock (6000.00) | Direct | |
| Stock Option (Right to Buy) | $14.4100 | 2012-03-08 | Common Stock (6000.00) | Direct | |
| Stock Option (Right to Buy) | $25.5300 | 2015-03-09 | Common Stock (3000.00) | Direct | |
| Stock Option (Right to Buy) | $19.3650 | 2015-05-05 | Common Stock (4000.00) | Direct |
Footnotes
F1: The option is exercisable in four equal installments beginning on the first anniversary of the grant.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27